Your Connection to the Latest HIV/AIDS, Hepatitis, STD and TB News at CDC
CDC Issues Provisional Guidance for Bedaquiline, a New Drug Available to Treat MDR TB
Following 20 years of declines, TB rates are at an all-time low in the United States (9,945 cases in 2012). However, drug resistance poses a serious threat to TB control nationally and around the world. While drug resistant cases account for a small portion of TB cases in the U.S., it is more difficult and costly to treat, more often fatal, and leaves patients with fewer treatment options.
Bedaquiline, approved by the FDA in December 2012, belongs to the first new class of TB drugs to be approved to treat this deadly disease in over 40 years. CDC has released provisional guidelines for the use of this drug, which is available to treat multidrug-resistant TB (MDR TB).
The new guidelines are published in the October 25, 2013 issue of the Morbidity and Mortality Weekly Report. Please find below materials to help you cover this important story.
News Releases and Announcements
- September 27, 2013 - National Gay Men's HIV/AIDS Awareness Day
National Gay Men’s HIV/AIDS Awareness Day reminds us that gay and bisexual men remain at the center of the HIV epidemic in the United States. While only representing two percent of the U.S. population, men who have sex with men (MSM) account for more than 60 percent of new infections and half of all Americans living with HIV. Young MSM are the only risk group where new infections are increasing, with a 22 percent increase in recent years.
For your stories about National Gay Men’s HIV/AIDS Awareness Day, please find below resources for your coverage of this important topic.
- Archive Previous Press Releases, Fact Sheets and Statements
HIV/AIDS, Hepatitis, STDs or TB
- (404) 639-8895
M-F 9am-5:30pm (ET)
All Other Topics
- (404) 639-3286
TTY: (888) 232-6348
New Hours of Operation